158 related articles for article (PubMed ID: 26132992)
1. Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
Thompson HJ; Sedlacek SM; Wolfe P; Paul D; Lakoski SG; Playdon MC; McGinley JN; Matthews SB
Nutrients; 2015 Jun; 7(7):5156-76. PubMed ID: 26132992
[TBL] [Abstract][Full Text] [Related]
2. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
[TBL] [Abstract][Full Text] [Related]
3. Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity.
Weiss EP; Reeds DN; Ezekiel UR; Albert SG; Villareal DT
Endocrine; 2017 Jan; 55(1):153-164. PubMed ID: 27605038
[TBL] [Abstract][Full Text] [Related]
4. Exercise and dietary advice intervention for survivors of triple-negative breast cancer: effects on body fat, physical function, quality of life, and adipokine profile.
Swisher AK; Abraham J; Bonner D; Gilleland D; Hobbs G; Kurian S; Yanosik MA; Vona-Davis L
Support Care Cancer; 2015 Oct; 23(10):2995-3003. PubMed ID: 25724409
[TBL] [Abstract][Full Text] [Related]
5. Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort.
Obi N; Jung AY; Maurer T; Huebner M; Johnson T; Behrens S; Jaskulski S; Becher H; Chang-Claude J
Sci Rep; 2021 Dec; 11(1):23526. PubMed ID: 34876619
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.
Macis D; Gandini S; Guerrieri-Gonzaga A; Johansson H; Magni P; Ruscica M; Lazzeroni M; Serrano D; Cazzaniga M; Mora S; Feroce I; Pizzamiglio M; Sandri MT; Gulisano M; Bonanni B; Decensi A
J Clin Oncol; 2012 Jan; 30(2):151-7. PubMed ID: 22162577
[TBL] [Abstract][Full Text] [Related]
7. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
8. Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial.
Llanos AA; Krok JL; Peng J; Pennell ML; Olivo-Marston S; Vitolins MZ; Degraffinreid CR; Paskett ED
Springerplus; 2014; 3():175. PubMed ID: 24790820
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.
Bavoso NC; Pinto JM; Soares MMS; Diniz MDS; Teixeira Júnior AL
An Bras Dermatol; 2019; 94(2):192-197. PubMed ID: 31090824
[TBL] [Abstract][Full Text] [Related]
10. An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.
Linkov F; Burke LE; Komaroff M; Edwards RP; Lokshin A; Styn MA; Tseytlin E; Freese KE; Bovbjerg DH
Gynecol Oncol; 2014 Apr; 133(1):67-72. PubMed ID: 24462731
[TBL] [Abstract][Full Text] [Related]
11. Effects of Diet and Exercise-Induced Weight Loss on Biomarkers of Inflammation in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Bruinsma TJ; Dyer AM; Rogers CJ; Schmitz KH; Sturgeon KM
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1048-1062. PubMed ID: 33737299
[TBL] [Abstract][Full Text] [Related]
12. Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study.
Liu FX; Flatt SW; Pakiz B; Sedjo RL; Wolin KY; Blair CK; Demark-Wahnefried W; Rock CL
Support Care Cancer; 2016 Jan; 24(1):173-180. PubMed ID: 25975675
[TBL] [Abstract][Full Text] [Related]
13. Adipocytokine imbalance and breast cancer in obese women.
Al Qteishat A; Aringazina R; Ermakov D; Demianenko E
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S827-S834. PubMed ID: 38384062
[TBL] [Abstract][Full Text] [Related]
14. Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.
Sedjo RL; Flatt SW; Byers T; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Wyatt H; Rock CL
Support Care Cancer; 2016 Aug; 24(8):3285-93. PubMed ID: 26945570
[TBL] [Abstract][Full Text] [Related]
15. Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.
Hofmann JN; Birmann BM; Teras LR; Pfeiffer RM; Wang Y; Albanes D; Baris D; Colditz GA; De Roos AJ; Giles GG; Hosgood HD; Lan Q; Landgren O; Liao LM; Rothman N; Weinstein SJ; Pollak MN; Neuhouser ML; Purdue MP
Cancer Res; 2016 Apr; 76(7):1935-41. PubMed ID: 26921332
[TBL] [Abstract][Full Text] [Related]
16. A change in objective sleep duration is associated with a change in the serum adiponectin level of women with overweight or obesity undergoing weight loss intervention.
Sawamoto R; Nozaki T; Furukawa T; Tanahashi T; Morita C; Hata T; Nakashima M; Komaki G; Sudo N
Obes Sci Pract; 2016 Jun; 2(2):180-188. PubMed ID: 27812383
[TBL] [Abstract][Full Text] [Related]
17. An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors.
Nwanaji-Enwerem JC; Chung FF; Van der Laan L; Novoloaca A; Cuenin C; Johansson H; Bonanni B; Hubbard AE; Smith MT; Hartman SJ; Cardenas A; Sears DD; Herceg Z
Clin Epigenetics; 2021 Dec; 13(1):224. PubMed ID: 34920739
[TBL] [Abstract][Full Text] [Related]
18. Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study.
Cava E; Spadaccini D; Aimaretti G; Marzullo P; Cavigiolo B; Farinelli D; Gennari A; Saggia C; Carbonelli MG; Riso S; Prodam F
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686676
[TBL] [Abstract][Full Text] [Related]
19. Diet Matters in Breast Cancer Prognosis: Clinical Trial Evidence and Questions.
McTiernan A
Clin Cancer Res; 2024 Mar; 30(5):931-933. PubMed ID: 38117468
[TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors.
Demark-Wahnefried W; Colditz GA; Rock CL; Sedjo RL; Liu J; Wolin KY; Krontiras H; Byers T; Pakiz B; Parker BA; Naughton M; Elias A; Ganz PA;
Breast Cancer Res Treat; 2015 Nov; 154(2):329-37. PubMed ID: 26518022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
